PACS Group (PACS) concentration risks

The company's concentration profile is defined by government payer dependency layered on top of a geographic concentration in a single state. On the payer side, Medicare accounted for 33.7% and Medicaid accounted for 40.5% of routine revenue for the year ended December 31, 2025 — both moderate-share, structural exposures by disclosed size. Together, these two federal and state government programs represented the substantial majority of routine revenue, a pattern that is inherent to the skilled nursing and post-acute care facility model. The structural character reflects the regulatory framework of long-term care reimbursement rather than a discretionary contract choice. The dependency risk embedded within these structural exposures is meaningful: Medicare and Medicaid reimbursement rates are set by federal and state regulatory bodies, and any adverse change to rate levels, eligibility criteria, or program structure could compress the revenue base across the entire portfolio simultaneously. Because both programs are present in every facility, there is no geographic offset within the facility mix if federal policy changes. Compounding the payer concentration, the majority of the company's leased facilities are in California — a moderate-share geographic concentration. California's Medi-Cal program governs a substantial portion of state Medicaid payments, and California-specific regulatory or reimbursement changes layer additional risk on top of the federal Medicaid dependency. Together, the concentration profile is payer-heavy and geographically anchored in California: federal reimbursement policy and California Medi-Cal rate dynamics are the primary variables to monitor.

For the engine’s reasoning on PACS’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.